Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Interest Coverage Ratio: 2021-2025

Historic Interest Coverage Ratio for Bicycle Therapeutics (BCYC) over the last 5 years, with Sep 2025 value amounting to -1,489.80.

  • Bicycle Therapeutics' Interest Coverage Ratio rose 23.00% to -1,489.80 in Q3 2025 from the same period last year, while for Sep 2025 it was -1,442.89, marking a year-over-year decrease of 1734.79%. This contributed to the annual value of -121.31 for FY2024, which is 108.40% down from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Interest Coverage Ratio is -1,489.80, which was up 7.10% from -1,603.74 recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Interest Coverage Ratio high stood at -17.37 for Q3 2021, and its period low was -1,934.73 during Q3 2024.
  • Over the past 3 years, Bicycle Therapeutics' median Interest Coverage Ratio value was -66.14 (recorded in 2023), while the average stood at -730.37.
  • Per our database at Business Quant, Bicycle Therapeutics' Interest Coverage Ratio rose by 25.33% in 2024 and then slumped by 3,463.33% in 2025.
  • Quarterly analysis of 5 years shows Bicycle Therapeutics' Interest Coverage Ratio stood at -21.98 in 2021, then crashed by 77.41% to -39.00 in 2022, then slumped by 69.61% to -66.14 in 2023, then tumbled by 1,867.35% to -1,301.21 in 2024, then climbed by 23.00% to -1,489.80 in 2025.
  • Its Interest Coverage Ratio stands at -1,489.80 for Q3 2025, versus -1,603.74 for Q2 2025 and -1,376.55 for Q1 2025.